BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Adaptimmune Reports Third Quarter 2017 Financial Results and Business Updates

  The company reported financial results and business updates for the quarter ended September 30, 2017.

  November 2, 2017

   · 

  6 min read
• Business

  Insmed Reports Third Quarter 2017 Financial Results and Provides Business Update

  For the third quarter of 2017, Insmed reported a net loss of $45.2 million, or $0.69 per share, compared with a net loss of $37.8 million, or $0.61 per share, for the third quarter of 2016.

  November 2, 2017

   · 

  16 min read
• Business

  Progenics Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Update

  Third quarter revenue totaled $2.7 million, down from $53.9 million in the third quarter of 2016, reflecting RELISTOR royalty income of $2.6 million compared to $3.3 million in the corresponding period of 2016.

  November 2, 2017

   · 

  13 min read
• Business

  CASMED to Report Third-Quarter 2017 Financial Results and Hold Conference Call on November 9

  Management will host a conference call to discuss these results and answer questions at 10:00 a.m. ET on the same day.

  November 2, 2017

   · 

  1 min read
• Business

  VBI Vaccines Strengthens Board of Directors With Appointment of Ran Nussbaum

  “We are honored to have Ran join our Board of Directors,” said Jeff Baxter, VBI’s president and CEO.

  November 2, 2017

   · 

  5 min read
• Business

  PLx Pharma to Discuss 2017 Third Quarter Financial Results on November 10, 2017 Conference Call

  Natasha Giordano, President and CEO, and Rita O’Connor, CFO, will host a conference call to discuss the results.

  November 2, 2017

   · 

  2 min read
• Biotech Bay

  goBalto Release: Industry Leader in Study Startup Releases Updated eBook on Starting Clinical Trials

  Since its inaugural release, the eBook has been downloaded over 62,000 times.

  November 2, 2017

   · 

  2 min read
• Deals

  Teva Announces Completion of Plan B One-Step Divestiture to Foundation Consumer Healthcare

  Teva to receive $675 million cash proceeds to progress repayment of term loan debt.

  November 2, 2017

   · 

  6 min read
• Business

  Evogene Financial Results for the Third Quarter of 2017 Earnings Announcement Schedule

  On the day of the announcement, the Company’s management will host a conference call to discuss the results at 09:00 AM ET.

  November 2, 2017

   · 

  2 min read
• BioMidwest

  Myriad Announces GeneSight Psychotropic Results From a Large Prospective Trial in Patients With Major Depressive Disorder

  This was the largest ever pharmacogenomics depression trial and primarily assessed Hamilton Depression Rating Scale 17 (HAMD-17) scores from baseline to eight weeks in patients receiving GeneSight-guided therapy compared to those receiving treatment-as-usual.

  November 2, 2017

   · 

  9 min read